Search the Newsreel

Madhav Infra Pr Standalone June 2026 Net Sales at Rs 57.35 crore, down 32.09% Y-o-Y

BHAV|BHAV Acquisition Units|Price:9.965|Chg%:-0.025

BHAV Acquisition Units (BHAV) is a blank check company aiming to merge with or acquire businesses in advanced/industrial robotics, EVs, drones/UAS, or fintech industries. The company currently has no operations or revenues. As of the article, its stock price is $9.980, with a market …

Is Haverty Furniture Companies Inc (HVT) Positioned for Growth A

Haverty Furniture Companies (HVT) Earnings Date and Reports 2026 $HVT

Haverty Furniture Companies Q2 2026 Earnings Call Transcript

Vaibhav Global Q1FY27 PAT surges 50% to ₹56 crore on margin gains

Biohaven (BHVN) Expected to Release Quarterly Earnings on Monday

Defilade Capital Management L.P. Buys Shares of 315,944 Biohaven Ltd. $BHVN

Shaver Shop's 7.1% Yield—Is This Unfashionable Retail Stock Secretly an Income Winner?

BHAV Acquisition Corp Revenue Breakdown – NASDAQ:BHAVU

This page provides financial information for BHAV Acquisition Corp (NASDAQ: BHAVU), including an overview of its financials, statements, statistics, dividends, earnings, and segment performance. The content is sourced from various financial data providers like ICE Data Services and FactSet, and SEC filings are provided …

Biohaven Ltd. $BHVN Shares Bought by Janus Henderson Group PLC

Biohaven Pharma earnings on deck amid epilepsy trial scrutiny

Biohaven Pharmaceutical Holding Co. is set to report second-quarter results, with analysts anticipating a narrower loss per share. Investors will be closely watching for updates on the company's cash runway and the timeline for pivotal Phase 2/3 epilepsy trial results for its experimental drug, …

Haverty Furniture Companies Inc expected to post earnings of 23 cents a share - Earnings Preview

Haverty Furniture Companies Inc (HVT) is anticipated to report earnings of 23 cents per share. This earnings preview highlights the market's expectations for the company's upcoming financial results.

Haverty Furniture Companies Inc (HVT) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis of Haverty Furniture Companies Inc (HVT), highlighting its current valuation score, P/E ratio, and its ranking within the Specialty Retailers industry. As of July 30, 2026, the company's valuation score is 6.63, placing it 77th out of 93 …

Biohaven Insiders Added US$33.1m Of Stock To Their Holdings

This article discusses recent insider purchases at Biohaven Pharmaceutical Holding Company. Insiders bought US$33.1 million worth of stock, suggesting confidence in the company's future despite a recent share price decline. The purchases come after the company's acquisition of a migraine drug by Pfizer, which …

Biohaven Ltd (BHVN) Cash Flow

This article provides a detailed quarterly and annual cash flow statement for Biohaven Ltd (BHVN), covering operating, investing, and financing activities. It also includes frequently asked questions explaining different types of cash flow and Biohaven's specific cash flow figures for operating, investing, financing, and …

Haverty Furniture Companies (NYSE:HVT) Share Price Passes Above 200-Day Moving Average - Time to Sell?

Haverty Furniture Companies (NYSE:HVT) saw its share price move above its 200-day moving average, trading at $25.9020 with a market cap of $416.76 million. The company recently reported quarterly earnings of $0.26 per share, hitting analyst consensus, and declared a quarterly dividend of $0.33 …

Haverty Furniture Companies Inc (HVT) Institutional Confidence

The article analyzes Haverty Furniture Companies Inc (HVT) institutional confidence score, which stands at 7.00, placing it 47th in the Specialty Retailers industry. Institutional shareholding is at 89.90%, showing a 5.68% increase quarter-over-quarter. Richard Pzena is identified as the largest institutional shareholder, holding 1.31M …

Biohaven (BHVN) Following Its Court Win Still Looks Cheap Against Fair Value

Biohaven (BHVN) recently won a federal jury case related to misappropriated trade secrets, yet its share price has seen a short-term decline despite strong 90-day and year-to-date gains. A Discounted Cash Flow (DCF) model estimates Biohaven's fair value at $61.24, significantly higher than its …

Haverty Furniture Companies Inc (HVT) Financial Health: Profitability & Balance Sheet Analysis

Haverty Furniture Companies Inc (HVT) currently holds a financial score of 7.04, placing it 51st out of 93 in the Specialty Retailers industry, indicating robust financial health and average operating efficiency. The company recently reported a quarterly revenue of $189.05 million, marking a 4.12% …

Havells India Standalone June 2026 Net Sales at Rs 6,509.97 crore, up 19.72% Y-o-Y

Why Are Shaver Shop (ASX:SSG) and Hearts and Minds (ASX:HM1) Drawing Income Attention?

Havertys Furniture Q2 Results: Earnings release date set for Aug 4

Havertys Furniture Companies, Inc. (NYSE: HVT) will release its second quarter 2026 financial results on August 4, 2026, before the market opens. Following the release, the company will host an investor conference call at 10:00 a.m. ET to discuss the results and provide strategic …

Havertys to release Q2 results before markets open Aug. 4

Havertys Furniture (NYSE: HVT, HVT.A) announced it will release its second quarter 2026 financial results on Tuesday, August 4, 2026, before the market opens. A conference call for investors and analysts will follow at 10:00 a.m. ET, with a live webcast and replay available …

Havertys Furniture To Announce Second Quarter 2026 Results on August 4, 2026

Haverty Furniture Companies, Inc. (NYSE: HVT and HVT.A) will release its second quarter 2026 financial results on Tuesday, August 4, 2026, before the market opens. This will be followed by a conference call with investors and analysts at 10:00 a.m. ET to discuss the …

Biohaven and Yale win $4M verdict in trade secret case

A federal jury awarded Biohaven Ltd. and Yale University $4 million in a trade secret misappropriation case against Avilar Therapeutics, Inc. and RA Capital Management GP, LLC. The jury found that Avilar and RA Capital willfully and maliciously misappropriated a Yale trade secret related …

Kochav Defense Acquisition Corp

Yale, Biohaven Win $4M In Biotech Trade Secret Trial

A Delaware federal jury has awarded Yale University and Biohaven Therapeutics $4 million in a biotech trade secret trial. The verdict found that venture capital firm RA Capital Management GP breached a confidentiality agreement and, along with Avilar Therapeutics, misappropriated a Yale-developed trade secret …

Yale, Biohaven Win $4 Million Verdict Over Drug-Development Tech

Yale University and Biohaven Therapeutics Ltd. were jointly awarded $4 million in a Delaware trial. The verdict found Avilar Therapeutics Inc. and RA Capital Management GP LLC liable for misappropriating Yale's "MODA" drug-development trade secret and for breaching a confidentiality agreement. The jury specifically …

Biohaven Awarded $1 Million Over Alleged Trade Secret Violations by Avilar Therapeutics, RA Capital Management

Biohaven (BHVN) said Monday that a federal jury has awarded it $1 million in damages over an alleged PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium news articles. …

Federal Jury Finds Avilar Therapeutics and RA Capital Willfully and Maliciously Misappropriated Trade Secret Developed at Yale, Awards Biohaven and Yale University $4 Million

A federal jury found Avilar Therapeutics and RA Capital Management GP, LLC guilty of willfully and maliciously misappropriating a trade secret developed at Yale University related to its "MODA" targeted protein degradation platform. RA Capital was also found to have breached a confidentiality agreement …

How Biohaven’s (BHVN) Trade Secret Verdict Shapes Its Intellectual Property Defense Strategy

Biohaven recently won a US$1,000,000 trade secret lawsuit, reinforcing its commitment to protecting intellectual property. While this win strengthens the narrative around IP quality, it doesn't change the company's core investment risks, which include clinical outcomes, funding needs, and potential shareholder dilution. Biohaven remains …

Biohaven Ltd (BHVN) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Biohaven Ltd (BHVN) stock, focusing on various indicators and moving averages. It presents a summary of buy, neutral, and sell signals derived from tools such as MACD, RSI, and different moving average periods. The analysis concludes with …

Haverty Furniture Companies Inc. (HVT) Q1 2026 Earnings: Slight EPS Miss Amid Modest Stock Gain - Revenue Miss Report

KCHV|Kochav Defense Acquisition Corp|Price:10.400|

Sadbhav Infrastructure Project Share Price Forecast to 2030